280 related articles for article (PubMed ID: 31262236)
21. Sample restrictions and the elicitation of a constant willingness to pay per quality adjusted life year.
Nielsen JS; Gyrd-Hansen D; Kjaer T
Health Econ; 2021 May; 30(5):923-931. PubMed ID: 33569834
[TBL] [Abstract][Full Text] [Related]
22. Analysis of factors affecting willingness to pay for cardiovascular disease-related medical services.
Yasunaga H; Ide H; Imamura T; Ohe K
Int Heart J; 2006 Mar; 47(2):273-86. PubMed ID: 16607054
[TBL] [Abstract][Full Text] [Related]
23. Willingness to pay for health care services in common cold, retinal detachment, and myocardiac infarction: an internet survey in Japan.
Yasunaga H; Ide H; Imamura T; Ohe K
BMC Health Serv Res; 2006 Feb; 6():12. PubMed ID: 16504017
[TBL] [Abstract][Full Text] [Related]
24. Value of a QALY and VSI estimated with the chained approach.
Olofsson S; Gerdtham UG; Hultkrantz L; Persson U
Eur J Health Econ; 2019 Sep; 20(7):1063-1077. PubMed ID: 31172400
[TBL] [Abstract][Full Text] [Related]
25. Estimating a WTP-based value of a QALY: the 'chained' approach.
Robinson A; Gyrd-Hansen D; Bacon P; Baker R; Pennington M; Donaldson C;
Soc Sci Med; 2013 Sep; 92():92-104. PubMed ID: 23849283
[TBL] [Abstract][Full Text] [Related]
26. Exploring the willingness to pay for a quality-adjusted life-year in the state of Penang, Malaysia.
Shafie AA; Lim YW; Chua GN; Hassali MA
Clinicoecon Outcomes Res; 2014; 6():473-81. PubMed ID: 25364267
[TBL] [Abstract][Full Text] [Related]
27. Estimating the range of incremental cost-effectiveness thresholds for healthcare based on willingness to pay and GDP per capita: A systematic review.
Iino H; Hashiguchi M; Hori S
PLoS One; 2022; 17(4):e0266934. PubMed ID: 35421181
[TBL] [Abstract][Full Text] [Related]
28. How you ask is what you get: Framing effects in willingness-to-pay for a QALY.
Ahlert M; Breyer F; Schwettmann L
Soc Sci Med; 2016 Feb; 150():40-8. PubMed ID: 26730880
[TBL] [Abstract][Full Text] [Related]
29. Willingness to pay for a quality-adjusted life year: an evaluation of attitudes towards risk and preferences.
Martín-Fernández J; Polentinos-Castro E; del Cura-González MI; Ariza-Cardiel G; Abraira V; Gil-LaCruz AI; García-Pérez S
BMC Health Serv Res; 2014 Jul; 14():287. PubMed ID: 24989615
[TBL] [Abstract][Full Text] [Related]
30. Determination of Cost-Effectiveness Threshold for Health Care Interventions in Malaysia.
Lim YW; Shafie AA; Chua GN; Ahmad Hassali MA
Value Health; 2017 Sep; 20(8):1131-1138. PubMed ID: 28964445
[TBL] [Abstract][Full Text] [Related]
31. Ex post and ex ante willingness to pay (WTP) for the ICT Malaria Pf/Pv test kit in Myanmar.
Cho-Min-Naing ; Lertmaharit S; Kamol-Ratanakul P; Saul AJ
Southeast Asian J Trop Med Public Health; 2000 Mar; 31(1):104-11. PubMed ID: 11023075
[TBL] [Abstract][Full Text] [Related]
32. The value of a QALY: individual willingness to pay for health gains under risk.
Bobinac A; van Exel J; Rutten FF; Brouwer WB
Pharmacoeconomics; 2014 Jan; 32(1):75-86. PubMed ID: 24293198
[TBL] [Abstract][Full Text] [Related]
33. The impact of the design of payment scales on the willingness to pay for health gains.
Soeteman L; van Exel J; Bobinac A
Eur J Health Econ; 2017 Jul; 18(6):743-760. PubMed ID: 27623946
[TBL] [Abstract][Full Text] [Related]
34. Is there a kink in consumers' threshold value for cost-effectiveness in health care?
O'Brien BJ; Gertsen K; Willan AR; Faulkner LA
Health Econ; 2002 Mar; 11(2):175-80. PubMed ID: 11921315
[TBL] [Abstract][Full Text] [Related]
35. Willingness-to-Pay for One Quality-Adjusted Life-Year: A Population-Based Study from Iran.
Lankarani KB; Ghahramani S; Moradi N; Shahraki HR; Lotfi F; Honarvar B
Appl Health Econ Health Policy; 2018 Dec; 16(6):837-846. PubMed ID: 30123949
[TBL] [Abstract][Full Text] [Related]
36. Comparing WTP values of different types of QALY gain elicited from the general public.
Pennington M; Baker R; Brouwer W; Mason H; Hansen DG; Robinson A; Donaldson C;
Health Econ; 2015 Mar; 24(3):280-93. PubMed ID: 25625510
[TBL] [Abstract][Full Text] [Related]
37. Quality-adjusted life years was a poor predictor of women's willingness to pay in acute and chronic conditions: results of a survey.
Franic DM; Pathak DS; Gafni A
J Clin Epidemiol; 2005 Mar; 58(3):291-303. PubMed ID: 15718119
[TBL] [Abstract][Full Text] [Related]
38. Willingness-to-pay stated preferences for 8 health-related quality-of-life domains in psoriatic arthritis: a pilot study.
Hu SW; Holt EW; Husni ME; Qureshi AA
Semin Arthritis Rheum; 2010 Apr; 39(5):384-97. PubMed ID: 19095293
[TBL] [Abstract][Full Text] [Related]
39. Willingness to pay for one quality-adjusted life year in Iran.
Moradi N; Rashidian A; Nosratnejad S; Olyaeemanesh A; Zanganeh M; Zarei L
Cost Eff Resour Alloc; 2019; 17():4. PubMed ID: 30867654
[TBL] [Abstract][Full Text] [Related]
40. Measuring the end-of-life premium in cancer using individual ex ante willingness to pay.
Olofsson S; Gerdtham UG; Hultkrantz L; Persson U
Eur J Health Econ; 2018 Jul; 19(6):807-820. PubMed ID: 28803265
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
